Jose A Carugno, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 38030 Daughtery Rd, Zephyrhills, FL 33540 Phone: 352-518-2000 Fax: 352-567-5193 |
Dr. Jennifer Lynne Harper, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 38030 Daughtery Rd, Zephyrhills, FL 33540 Phone: 352-518-2000 Fax: 352-567-0218 |
Annette Suzanne Williams, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7050 Gall Blvd, Zephyrhills, FL 33541 Phone: 813-782-8761 Fax: 813-783-6038 |
Mrs. Maria Olga Villa, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7050 Gall Blvd, Zephyrhills, FL 33541 Phone: 813-782-8761 Fax: 813-783-6038 |
Mona Carol Mccullough, M.D. Obstetrics & Gynecology - Female Pelvic Medicine and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 6719 Gall Blvd Ste 208, Zephyrhills, FL 33542 Phone: 813-782-7318 Fax: 813-788-5067 |
Dr. John A Ferlita, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6719 Gall Blvd, Suite #208, Zephyrhills, FL 33542 Phone: 813-782-7318 Fax: 813-788-5067 |
Dr. Donna E Connors, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 38030 Daughtery Rd, Zephyrhills, FL 33540 Phone: 352-518-2000 Fax: 352-567-0218 |
Dr. Michael Ivan Weiss, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7050 Gall Blvd, Zephyrhills, FL 33541 Phone: 813-782-8761 Fax: 813-783-6038 |
Dr. William Kimball Bradfield, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7050 Gall Blvd, Zephyrhills, FL 33541 Phone: 813-782-8761 |
News Archive
The U.S. Food and Drug Administration has approved Onglyza (saxagliptin), a once-daily tablet to treat Type 2 diabetes in adults. The medication is intended to be used with diet and exercise to control high blood sugar levels.
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
The interaction of the drug compstatin with two ancient, co-evolved human systems points to new ways for reducing clotting during dialysis for end-stage kidney disease and multiple organ failure due to sepsis, a dangerous whole-body inflammatory response to infection.
Two distinctive handfuls of short molecules that regulate gene expression have been found in the eye fluid of patients with two distinct types of vision degenerating glaucoma.
Streptococcus mutans, one of the principal bacteria that cause dental caries, has increased the change in its genetic material over time, possibly coinciding with dietary change linked to the expansion of humanity.
› Verified 3 days ago